LISTED medication adherence provider MedAdvisor says it believes there are still significant opportunities for growth within the Australian market, after reaching one million connected patients.
CEO Robert Read said there are more than 12 million people suffering from a chronic disease in Australia alone, "so with MedAdvisor's Pharmacy Network representing about 50% of pharmacies, MedAdvisor can significantly improve health outcomes for a much larger portion of the domestic population".
He said patient user growth was an important driver, with additional opportunities to boost income becoming available as the user base increases.
"As patient reach expands it adds further revenue opportunities for Patient Engagement Programs and enhances the capacity of the business to generate transactional revenue," Read added.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Apr 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Apr 18